Kiniksa Pharmaceuticals International, plc logo KNSA - Kiniksa Pharmaceuticals International, plc

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $70.80 DETAILS
HIGH: $75.00
LOW: $62.00
MEDIAN: $72.00
CONSENSUS: $70.80
DOWNSIDE: 10.88%

Profitability Ratios

Ratio Value
GP Margin 54.6%
EBIT Margin 13.1%
EBITDA Margin 13.3%
Operating Margin 11.4%
Pretax Margin 13.1%
Cont. Ops Margin 8.7%
Net Margin 8.7%
Bottom Line Margin 8.7%

Liquidity Ratios

Ratio Value
Current Ratio 3.79
Quick Ratio 3.39
Solvency Ratio 0.309
Cash Ratio 1.19

Valuation Ratios

Ratio Value
Price/Earnings
51.56
Hist. avg: 48.3
Peers avg: 27.5
PEG Ratio -0.22
Forward PEG -0.22
Price/Book 5.39
Price/Sales 4.52
Price/FCF 120.45
Price/Op Cash Flow 119.15

Debt Ratios

Ratio Value
Debt/Assets 0.0124
Debt/Equity 0.0167
Debt/Capital 0.0165
Long-Term Debt/Capital 0.0000
Financial Leverage 1.35

Cash Flow Ratios

Ratio Value
Working Capital Turnover 2.19
Operating Cash Flow Ratio 0.185
Operating Cash Flow/Sales 3.8%
Free Cash Flow/Operating Cash Flow 98.9%

Coverage Ratios

Ratio Value
Debt Service Coverage 20.27
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 8.60
Operating Cash Flow Coverage 2.70
Capital Expenditure Coverage 92.74
Dividend + Capital Expenditure Coverage 92.74

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 9.13
EPS 0.795
Debt/Share 0.1280
Cash/Share 5.58
Book Value/Share 7.65
Tangible BV/Share 7.44
Equity/Share 7.65
Operating Cash Flow/Share 0.346
Capital Expenditure/Share 0.004
FCF/Share 0.342

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.664
Earnings Before Tax/EBIT 1.151
Price/Fair Value 5.39
Debt/Market Cap 0.0010
Effective Tax Rate 33.6%
Enterprise Value Multiple 32.12